Durie BG - Search Results

1

A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

Durie BG, Salmon SE. Durie BG, et al. Cancer. 1975 Sep;36(3):842-54. doi: 10.1002/1097-0142(197509)36:3<842::aid-cncr2820360303>3.0.co;2-u. Cancer. 1975. PMID: 1182674

2

Spontaneous secretion of tumor necrosis factor-beta by human myeloma cell lines.

Bataille R, Klein B, Jourdan M, Rossi JF, Durie BG. Bataille R, et al. Among authors: durie bg. Cancer. 1989 Mar 1;63(5):877-80. doi: 10.1002/1097-0142(19890301)63:5<877::aid-cncr2820630514>3.0.co;2-6. Cancer. 1989. PMID: 2783661

3

Cellular kinetics in multiple myeloma. A new approach to staging and treatment.

Salmon SE, Durie BG. Salmon SE, et al. Among authors: durie bg. Arch Intern Med. 1975 Jan;135(1):131-8. Arch Intern Med. 1975. PMID: 1089396

4

International uniform response criteria for multiple myeloma.

Durie BG, Harousseau JL, Miguel JS, Bladé J, Barlogie B, Anderson K, Gertz M, Dimopoulos M, Westin J, Sonneveld P, Ludwig H, Gahrton G, Beksac M, Crowley J, Belch A, Boccadaro M, Cavo M, Turesson I, Joshua D, Vesole D, Kyle R, Alexanian R, Tricot G, Attal M, Merlini G, Powles R, Richardson P, Shimizu K, Tosi P, Morgan G, Rajkumar SV; International Myeloma Working Group. Durie BG, et al. Leukemia. 2006 Sep;20(9):1467-73. doi: 10.1038/sj.leu.2404284. Epub 2006 Jul 20. Leukemia. 2006. PMID: 16855634

5

International staging system for multiple myeloma.

Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Bladé J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA, Lahuerta JJ, Ludwig H, Morgan G, Powles R, Shimizu K, Shustik C, Sonneveld P, Tosi P, Turesson I, Westin J. Greipp PR, et al. Among authors: durie bg. J Clin Oncol. 2005 May 20;23(15):3412-20. doi: 10.1200/JCO.2005.04.242. Epub 2005 Apr 4. J Clin Oncol. 2005. PMID: 15809451

6

Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project.

Usmani SZ, Hoering A, Cavo M, Miguel JS, Goldschimdt H, Hajek R, Turesson I, Lahuerta JJ, Attal M, Barlogie B, Lee JH, Kumar S, Lenhoff S, Morgan G, Rajkumar SV, Durie BGM, Moreau P. Usmani SZ, et al. Blood Cancer J. 2018 Nov 23;8(12):123. doi: 10.1038/s41408-018-0155-7. Blood Cancer J. 2018. PMID: 30470751 Free PMC article.

7

Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group.

Moulopoulos LA, Koutoulidis V, Hillengass J, Zamagni E, Aquerreta JD, Roche CL, Lentzsch S, Moreau P, Cavo M, Miguel JS, Dimopoulos MA, Rajkumar SV, Durie BGM, Terpos E, Delorme S. Moulopoulos LA, et al. Blood Cancer J. 2018 Oct 4;8(10):95. doi: 10.1038/s41408-018-0124-1. Blood Cancer J. 2018. PMID: 30287814 Free PMC article.

8

Role of new treatment approaches in defining treatment goals in multiple myeloma--the ultimate goal is extended survival.

Durie BG. Durie BG. Cancer Treat Rev. 2010 May;36 Suppl 2:S18-23. doi: 10.1016/S0305-7372(10)70008-6. Cancer Treat Rev. 2010. PMID: 20472184 Review.

9

The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.

Durie BG. Durie BG. Eur J Cancer. 2006 Jul;42(11):1539-43. doi: 10.1016/j.ejca.2005.11.037. Epub 2006 Jun 13. Eur J Cancer. 2006. PMID: 16777405

10

Serum beta2 microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging.

Bataille R, Durie BG, Grenier J. Bataille R, et al. Among authors: durie bg. Br J Haematol. 1983 Nov;55(3):439-47. doi: 10.1111/j.1365-2141.1983.tb02158.x. Br J Haematol. 1983. PMID: 6357266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results